TScan Therapeutics, Inc. (TCRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 129.86M |
| Enterprise Value | 71.59M |
| P/E Ratio | -0.2 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 1.66 |
| Price/Book Ratio | 0.35 |
| Enterprise/Revenue | 0.35 |
| Enterprise/EBITDA | -0.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -16.55 |
| Operating Margin | -16.95 |
| Return On Assets | -0.69 |
| Return On Equity | -1.09 |
| Revenue | 10.33M |
| Revenue/Share | 0.05 |
| Gross Profit | 7.46M |
| EBITDA | -124.13M |
| Net Income | -129.77M |
| Diluted EPS | -1 |
| Total Cash | 73.04M |
| Total Cash/Share | 0.77 |
| Total Debt | 72.01M |
| Total Debt/Equity | 1.32 |
| Current Ratio | 3.37 |
| Book Value Per Share | 0.53 |
| 52-Week Change | -84.4 |
| 52-Week High | 1.47 |
| 52-Week Low | 0.17 |
| Moving Average 50 Days | 0.27 |
| Moving Average 200 Days | 0.81 |
| Average Volume | 749,629 |
| Shares Outstanding | 63.5M |
| % Held by Institutions | 27.58 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |